The Lockwood Group, LLC

Freelance Senior Scientific Director - Promotional Med Ed

United States

The Lockwood Group, LLC Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotech, Medical DevicesIndustries

Requirements

Candidates must possess an advanced degree in science, and a minimum of 10 years of relevant job experience with promotional medical education content such as advisory boards, speaker programs, and slide decks. Demonstrated organizational, analytical, and interpersonal communication skills are required, along with the ability to analyze and interpret scientific data, multitask, work independently, and manage projects within tight deadlines with limited direction. Experience with established professional medical editorial processes (e.g., AMA style) and ethical guidelines is also necessary. Specific experience in psychiatry, particularly with schizophrenia, bipolar disorder, and/or major depressive disorder, is required.

Responsibilities

The Senior Scientific Director will be responsible for the planning, development, and oversight of scientific content for assigned accounts across various therapeutic areas, leading client interactions and brand strategy, managing resource allocation, partnering with client services to develop SOWs and timelines, and identifying areas for new and organic growth. They will also lead the scientific portion of brand planning and business development, and contribute to the development of evidence-based, clinically relevant programs that contribute to the development of clients’ brands.

Skills

Scientific Content Development
Medical Communications
Account Management
Client Interaction
Brand Strategy
Resource Allocation
Business Development
Therapeutic Area Knowledge

The Lockwood Group, LLC

Healthcare consulting for drug development support

About The Lockwood Group, LLC

The Lockwood Group provides consulting services specifically for the healthcare and pharmaceutical industries, focusing on clients in the later stages of drug development, particularly after Phase 2 clinical trials. The company assists pharmaceutical and biotech firms by creating strategic publication plans that communicate scientific data and research findings accurately and in compliance with regulatory standards. They also support clients during the prelaunch phase of their products by identifying market needs and collaborating through the launch process to ensure success. A unique aspect of The Lockwood Group is its medical animation affiliate, Random42, which produces engaging and scientifically accurate visual content to help convey complex information. Their business model is based on service fees for consulting and project work, with a commitment to delivering high-quality communications and strategic support to help clients thrive in the competitive healthcare landscape.

Key Metrics

Stamford, ConnecticutHeadquarters
2007Year Founded
ACQUISITIONCompany Stage
Consulting, HealthcareIndustries
201-500Employees

Benefits

Remote Work Options
Flexible Work Hours

Risks

Emerging firms using AI-driven content creation threaten market share.
Pharmaceutical companies developing in-house teams may reduce demand for external services.
Tightening EU regulatory standards could increase compliance costs.

Differentiation

Specializes in healthcare and pharmaceutical sectors, focusing on advanced drug development stages.
Offers strategic publication plans tailored to specific audiences and regulatory standards.
Provides commercial support during prelaunch, launch, and post-launch phases.

Upsides

Increased demand for digital health solutions boosts growth in medical communications.
Rise of personalized medicine creates opportunities for specialized communication strategies.
Integration of AI enhances publication strategies and data analysis capabilities.

Land your dream remote job 3x faster with AI